|
Global Hepatitis Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Celgene Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Myocardial Infarction Partnering 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global E-Coli Partnering 2010-2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 |
Sep 1 2017 |
1000 |
Global |
$2,995.00 |
|
|
Nektar Therapeutics Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Peptic Ulcer Partnering 2010-2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Idiopathic Pulmonary Fibrosis Partnering 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
3SBio Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
UCB Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Chronic Kidney Disease Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Enzo Biochem Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Epilepsy Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Global Retinopathy Partnering 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Hematology Partnering 2010-2017: Deal trends, players and financials |
Sep 1 2017 |
600 |
Global |
$2,995.00 |
|
|
Roche Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Apotex Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Colorectal Cancer Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Global MRSA Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Immunomedics Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Bristol-Myers Squibb Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Non-Small Cell Lung Cancer Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Global Respiratory Syncytial Virus Partnering 2010-2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Global Diagnostic Imaging Partnering Terms and Agreements 2010 to 2017 |
Sep 1 2017 |
567 |
Global |
$2,995.00 |
|
|
Morphosys Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Irritable Bowel Syndrome Partnering 2010-2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Global Asthma Partnering 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Sensory Organ Partnering 2010-2017: Deal trends, players and financials |
Sep 1 2017 |
200 |
Global |
$2,995.00 |
|
|
Teva Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Cystic Fibrosis Partnering 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
